Proteomics secures Australian patent for endometriosis test
Proteomics International has locked in a key Australian patent for its PromarkerEndo test, a significant step in its global commercialisation strategy for the endometriosis diagnostic.
We haven't written up this one. The Age has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
